This inventor holds 7 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: Gruenenthal Gmbh, Grunenthal Gmbh, Lts Lohmann Therapie-Systeme Ag. Active years: 2013-2019.
Location History:
- Inden, DE (2013 - 2018)
- Aachen, DE (2018 - 2019)
Company Filing History:
4 out of 360 
3 out of 107 
1 out of 333 
Years Active: 2013-2019
Title: The Innovative Contributions of Eric Galia
Introduction
Eric Galia is a notable inventor based in Aachen, Germany. He has made significant contributions to the field of pharmaceuticals, holding a total of seven patents. His work focuses on developing advanced dosage forms that enhance drug delivery and efficacy.
Latest Patents
Among his latest patents is the "Oxidation-stabilized tamper-resistant dosage form," which is a thermoformed pharmaceutical dosage form designed to withstand a breaking strength of at least 300 N. This innovation aims to improve the safety and reliability of medication delivery. Another significant patent is related to "Transdermal administration of memantine." This invention involves transdermal therapeutic systems (TTS) that utilize memantine, an NMDA receptor antagonist, as an active ingredient. These systems are intended for treating various diseases of the central nervous system.
Career Highlights
Eric Galia has worked with Gruenenthal GmbH, a prominent pharmaceutical company known for its innovative approaches to drug development. His experience in this company has allowed him to contribute to groundbreaking advancements in pharmaceutical formulations.
Collaborations
Throughout his career, Eric has collaborated with notable colleagues, including Lutz Barnscheid and Johannes Bartholomäus. These partnerships have fostered a creative environment that has led to the development of impactful pharmaceutical solutions.
Conclusion
Eric Galia's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of effective drug delivery systems.